Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.065 | 0.7 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |